DrugTimes

New Business

China’s drug prowess on show at global event, drawing industry ‘shoppers’: Jefferies

China’s cost and efficiency advantages in drug development have been recognised at the world’s largest cancer research conference in the…

Read More »
New Business

Chinese biotech’s mega drug-licensing deals with multinationals surge on cost savings

A potential multibillion-dollar deal unveiled on Friday by CSPC Pharmaceutical Group is the latest in a growing number of agreements…

Read More »
Back to top button